Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Callison

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|February 7, 2019
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell ActivationAndrea Marzi, Andrea R Menicucci, Flora Engelmann, et al.
Microorganisms|June 2, 2021
Favipiravir (T-705) Protects IFNAR<sup>-/-</sup> Mice against Lethal Zika Virus Infection in a Sex-Dependent MannerKeesha Matz, Jackson Emanuel, Julie Callison, et al.
Frontiers in Immunology|November 15, 2021
Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus DiseaseAndrea Marzi, Allen Jankeel, Andrea R Menicucci, et al.
Ebiomedicine|October 22, 2019
Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challengeAndrea Marzi, Pierce Reynolds, Reinaldo Mercado-Hernandez, et al.
Frontiers in Cellular and Infection Microbiology|April 27, 2018
Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out MiceAndrea Marzi, Jackson Emanuel, Julie Callison, et al.
JCI Insight|December 27, 2022
Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaquesKyle Rosenke, Matt C Lewis, Friederike Feldmann, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus MacaquesKyle Rosenke, Matt C Lewis, Friederike Feldmann, et al.
Frontiers in Immunology|September 21, 2023
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus diseaseThomas P Monath, Richard Nichols, Friederike Feldmann, et al.
Journal of Virology|July 28, 2010
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatmentBarry Rockx, Katharine N Bossart, Friederike Feldmann, et al.
Emerging Microbes & Infections|November 2, 2021
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primatesKyle Rosenke, Friederike Feldmann, Atsushi Okumura, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 7, 2019
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell ActivationAndrea Marzi, Andrea R Menicucci, Flora Engelmann, et al.
Microorganisms|June 2, 2021
Favipiravir (T-705) Protects IFNAR<sup>-/-</sup> Mice against Lethal Zika Virus Infection in a Sex-Dependent MannerKeesha Matz, Jackson Emanuel, Julie Callison, et al.
Frontiers in Immunology|November 15, 2021
Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus DiseaseAndrea Marzi, Allen Jankeel, Andrea R Menicucci, et al.
Ebiomedicine|October 22, 2019
Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challengeAndrea Marzi, Pierce Reynolds, Reinaldo Mercado-Hernandez, et al.
Frontiers in Cellular and Infection Microbiology|April 27, 2018
Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out MiceAndrea Marzi, Jackson Emanuel, Julie Callison, et al.
JCI Insight|December 27, 2022
Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaquesKyle Rosenke, Matt C Lewis, Friederike Feldmann, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus MacaquesKyle Rosenke, Matt C Lewis, Friederike Feldmann, et al.
Frontiers in Immunology|September 21, 2023
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus diseaseThomas P Monath, Richard Nichols, Friederike Feldmann, et al.
Journal of Virology|July 28, 2010
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatmentBarry Rockx, Katharine N Bossart, Friederike Feldmann, et al.
Emerging Microbes & Infections|November 2, 2021
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primatesKyle Rosenke, Friederike Feldmann, Atsushi Okumura, et al.
Pageof 3